Literature DB >> 3145093

Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy.

D M Lapadula1, E Suwita, M B Abou-Donia.   

Abstract

The present studies were carried out to investigate the comparative roles of protein cross-linking and alteration in protein phosphorylation in the accumulation of neurofilaments due to aliphatic hexacarbons. In these studies, rats were given 2,5-hexanedione (0, 0.1, 0.25 and 1.0%) for 70 days in their drinking water. In a separate study of in vitro protein phosphorylation rats were given 1% 2,5-hexanedione for 14 days in their drinking water. Spinal cord neurofilaments were isolated and analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, immunoblotting using anti-neurofilament antibodies, radioimmunoassays (RIAs) of phosphorylated epitopes on neurofilament proteins and protein phosphorylation. Protein cross-linking of neurofilaments was found in all animals treated with 2,5-hexanedione including the lowest dose (0.1%) which did not produce clinical signs of intoxication. Protein phosphorylation of neurofilament proteins, as well as MAP-2 was significantly decreased upon treatment. Protein staining revealed a decreased amount of neurofilament protein and immunoblotting demonstrated neurofilament protein cross-linking in these animals. Protein staining of glial fibrillary acidic protein (GFAP) was unaltered by this treatment. RIAs of phosphorylated and non-phosphorylated epitopes of neurofilament proteins indicated that in vivo phosphorylation of these proteins was also decreased. Two-dimensional gel electrophoresis indicated a shift of the neurofilament proteins to a basic pI, indicating a dephosphorylation of neurofilament proteins. Cross-linked neurofilament proteins also exhibited a pI which was more basic than any of the individual neurofilament proteins. This report demonstrates differential effects of 2,5-hexanedione on neurofilament proteins and indicates that several mechanisms may be responsible for their accumulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145093     DOI: 10.1016/0006-8993(88)90503-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro.

Authors:  G Moretto; S Monaco; M G Passarin; M D Benedetti; N Rizzuto
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  In vivo inactivation of transglutaminase during the acute acrylamide toxic syndrome in the rat.

Authors:  C M Bergamini; M Signorini
Journal:  Experientia       Date:  1990-03-15

3.  Quantitative alterations of S-100 protein and neuron specific enolase in the rat nervous system after chronic 2,5-hexanedione exposure.

Authors:  J E Karlsson; S Wang; L E Rosengren; K G Haglid
Journal:  Neurochem Res       Date:  1993-02       Impact factor: 3.996

4.  Occupational exposure to n-hexane in Italy--analysis of a registry of biological monitoring.

Authors:  A Baldasseroni; P Bavazzano; V Li Donni; E Buiatti; E Lanciotti; C Lorini; S Toti; A Biggeri
Journal:  Int Arch Occup Environ Health       Date:  2003-02-15       Impact factor: 3.015

5.  In vitro binding of [14C]2,5-hexanedione to rat neuronal cytoskeletal proteins.

Authors:  C L Lanning; K R Wilmarth; M B Abou-Donia
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

6.  Time-dependent alteration of cytoskeletal proteins in cerebral cortex of rat during 2,5-hexanedione-induced neuropathy.

Authors:  Fuyong Song; Cuili Zhang; Sufang Yu; Xiulan Zhao; Lihua Yu; Keqin Xie
Journal:  Neurochem Res       Date:  2007-04-20       Impact factor: 3.996

7.  2,5-hexanedione induced apoptosis in mesenchymal stem cells from rat bone marrow via mitochondria-dependent caspase-3 pathway.

Authors:  Ruolin Chen; Shuang Liu; Fengyuan Piao; Zhemin Wang; Yuan Qi; Shuangyue Li; Dongmei Zhang; Jingshun Shen
Journal:  Ind Health       Date:  2015-01-29       Impact factor: 2.179

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.